top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Antiviral Agents
Antiviral Agents
Autore Adamson Catherine
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (386 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato Zika virus
nucleoside analogues
antiviral agents
NS5
prodrugs
ProTides
neural stem cells
RNA-dependent RNA polymerase
cytomegalovirus
latent infection
TALEN
Surveyor nuclease mutation detection assay
ie-1 gene
quantitative real-time PCR
Epstein-Barr virus
herpes viruses
lytic gene expression
Burkitt lymphoma cells
clozapine
antipsychotic drug
antiviral drug
enteroviruses
coxsackievirus B4
persistent infection
fluoxetine
resistance
mutations
herpes B virus
macacine herpesvirus-1
genistein
flavonoids
acyclovir
ganciclovir
Plantago asiatica
Clerodendrum trichotomum
RSV
therapeutic effects
acteoside
human antimicrobial peptides
antiviral strategies
defensins
cathelicidins
hepcidins
transferrins
influenza A virus
brevilin A
antiviral
sesquiterpene lactone
replication
PRRSV
polyethylenimine
PEI
virion internalization
endocytosis
HIV
pediatrics
Ethiopia
pre-treatment drug resistance
combination antiretroviral therapy (cART)
dried plasma spots
dried blood spots
sphingolipids
glycosphingolipids
viruses
lipid biosynthesis
flavivirus
Japanese encephalitis virus
furin inhibitor
precursor membrane protein
measles virus
central nervous system
tropism
treatments
porcine reproductive and respiratory syndrome virus
ginsenoside Rg1
antiviral activity
pro-inflammatory factor
NF-κB signaling pathway
acute/latent infection
congenital infection
antiviral agent
therapeutic strategies
nucleic acid-based therapeutic approach
HCMV vaccine
adoptive cell therapy
Rev response element
chemical footprinting
SHAPE
drug discovery
branched peptides
herpesvirus
immediate-early
IE1
IE2
ribozyme
RNA interference
CRISPR/Cas
small molecule
orthohantavirus
phenyl-benzotriazoles
C-FRA
Porcine circovirus type 2
epigallocatechin gallate
heparan sulfate
antiviral effect
virus attachment
microvirin
lectin
human immunodeficiency virus
hepatitis C virus
antiviral inhibitor
non-immunogenic
viral entry
protein drugs
LUMS1
oleanane-type derivatives
influenza A virus (IAV)
virus entry inhibitors
hemagglutinin (HA)
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557448703321
Adamson Catherine  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Fibroblast Growth Factor Receptor (FGFR) Signaling Pathway in Tumor
Fibroblast Growth Factor Receptor (FGFR) Signaling Pathway in Tumor
Autore Holzmann Klaus
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (276 p.)
Soggetto topico Medicine
Soggetto non controllato FGFR4
FGF19
gene regulation
cancer signaling
anticancer
FRS2
FGFR
NVP-BGJ398
LY2874455
sarcoma
cancer-associated fibroblasts
GPER
breast cancer
estrogen
FGFR1
FGF2
optogenetics
ERK
AKT
receptor kinase
neurite outgrowth
HEK293
PC12
fibroblast growth factor receptors
signaling
receptor cross-talk
coreceptor
membrane proteins
FGFR2
ERK1/2
phosphorylation
serine
negative feedback loop
cancer
prognosis
HCC
inhibitors
FGF
fibroblast growth factor
autocrine signaling
skin
melanoma
squamous and basal cell carcinoma
seborrheic keratosis
targeted therapy
resistance
structure
kinase inhibitor
gastric cancer
monoclonal antibody
small molecule
FGFR2c
autophagy
keratinocyte
MTOR
JNK1
review
malignant glioma
brain cancer
astrocytoma
Sprouty proteins
FGF-mediated signaling
tumor suppressor
tumor promoter
malignant pleural mesothelioma
overall survival
immunohistochemistry
infigratinib sensitivity
FGF8
FGF18
adenocarcinoma of the esophagogastric junction
neoadjuvant therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Fibroblast Growth Factor Receptor
Record Nr. UNINA-9910557898903321
Holzmann Klaus  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Oncolytic Virus Immunotherapy
Oncolytic Virus Immunotherapy
Autore Marchini Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (366 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato oncolytic viruses
melanoma
immunotherapy
checkpoint inhibitors
combinatory therapy
reovirus
oncolytic virus
adenovirus
oncolytic
virotherapy
targeting
immunogenic cell death
αvβ6 integrin
oncolytic adenovirus
cancer immunotherapy
multi-stage
immunostimulatory
arming
HSV-1
clinical trials
newcastle disease virus
NDV
cancer
immune checkpoint inhibitor
PD-1
PD-L1
CTLA-4
type I interferon
herpes simplex virus
retargeted virus
tropism retargeting
tumor
checkpoint inhibitor
vaccination
antigen-agnostic vaccination
HER2
parvovirus
tumor microenvironment
combination therapy
glioblastoma
pancreatic cancer
colorectal cancer
measles virus
vector engineering
immune checkpoint blockade
antitumor immune response
delivery
genetic modification
biomarkers
personalized oncolyticvirotherapy
class I HLA
immunosurveillance
immunoediting
oncogenic signaling
RAS
DNA methyltransferase inhibitor (DNMTi)
viral mimicry
epigenetic silencing
adoptive T cell therapy
CAR T cell
pancreatic ductal adenocarcinoma
vesicular stomatitis virus
small molecule
cancer immune therapy
cancer therapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566462203321
Marchini Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui